Table 1 Patient characteristics
n (%) | ER+ | ER- | |
|---|---|---|---|
Number of patients | 67 | 33 | 34 |
Age (years) | |||
Median | 51 | 57 | 48 |
Range | 30–93 | 34–93 | 30–75 |
TNM stage | |||
I | 6 (9%) | 4 (12%) | 2 (6%) |
II | 2 (3%) | 1 (3%) | 1 (3%) |
IIA | 23 (35%) | 12 (37%) | 11 (32%) |
IIB | 21 (31%) | 7 (21%) | 14 (41%) |
IIIA | 9 (13%) | 5 (15%) | 4 (12%) |
IIIB | 6 (9%) | 4 (12%) | 2 (6%) |
N category | |||
pN0 | 37 (55%) | 17 (52%) | 20 (59%) |
pN1 | 24 (35%) | 13 (39%) | 11 (32%) |
pN2 | 5 (8%) | 3 (9%) | 2 (6%) |
Missing | 1 (2%) | 0 (0%) | 1 (3%) |
Grade | |||
G1 | 8 (12%) | 8 (24%) | 0 (0%) |
G2 | 20 (30%) | 14 (43%) | 6 (18%) |
G3 | 29 (43%) | 7 (21%) | 22 (64%) |
Missing | 10 (15%) | 4 (12%) | 6 (18%) |
Neoadjuvant therapy | |||
Yes | 6 (9%) | 2 (6%) | 4 (12%) |
No | 50 (75%) | 26 (79%) | 24 (70%) |
Missing | 11 (16%) | 5 (15%) | 6 (18%) |